Oncology Adjuvants Market Players:
- Sanofi S.A
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Amgen Inc.
- Bristol Myers Squibb
- Eli Lilly and Company
- Biogen AstraZeneca plc
- Pfizer Inc.
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- SL Pharmaceutical
- Sanjiu Medical
- Hisun Pharmaceuticals USA Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of oncology adjuvants is evaluated at USD 619.49 million.
The global oncology adjuvants market size was worth over USD 588.76 million in 2025 and is poised to grow at a CAGR of more than 5.8%, reaching USD 1.03 billion revenue by 2035.
North America oncology adjuvants market achieves a 35% share by 2035, driven by rising incidence of cancer, large patient population, and good healthcare facilities.
Key players in the market include Amgen Inc., Bristol Myers Squibb, Eli Lilly and Company, Biogen AstraZeneca plc, Pfizer Inc., Jiangsu Hengrui Pharmaceuticals Co., Ltd. .
